$HCTI Income Statement | Understand Stock

$HCTI

$6.43 -$0.37 (5.44%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net revenue
Cost of revenue (exclusive of depreciation and amortization shown separately below)
Gross margin
Operating expenses
Sales and marketing
General and administrative
Impairment expense
Research and development
Bad debts expense
Depreciation and amortization
Total operating expenses
Loss from operations
Other income
Total other income/(expenses)
Changes in fair value
Forex loss
Interest expense
Loss before income tax
State income tax
Provision for income tax
Net loss
Net loss per common share—basic and diluted
Basic and diluted
Other comprehensive income/(loss)
Foreign currency translation gain
Deemed dividend
Total other comprehensive loss
Comprehensive loss
Comprehensive loss attributable to:
Stockholders
Non-controlling interest
Net loss per common share - basic and diluted, attributable to:
Stockholders (in Dollars per share)
Stockholders - diluted (in Dollars per share)
Non-controlling interest - basic (in Dollars per share)
Non-controlling interest - diluted (in Dollars per share)
Weighted average shares outstanding used in per common share computations:
Basic (in Shares)
Diluted (in Shares)

Comments